Beovu 6 mg/0.05 mL injection Images
Generic Name: brolucizumab
This medication has been identified as Beovu 6 mg/0.05 mL injection. It is supplied by Novartis Pharmaceuticals Corporation.
Beovu is used in the treatment of Diabetic Macular Edema; Macular Degeneration and belongs to the drug class anti-angiogenic ophthalmic agents. Beovu 6 mg/0.05 mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
More about Beovu (brolucizumab)
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- En español
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.